|
⚲
|
| Keyboard |
| Vaughn Kailian | |
|---|---|
| Firm | |
| Address | 510 Meadowmont Village Circle Suite 283 Chapel Hill, NC 27517 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Vascular Pharmaceuticals Inc | 021-201791 | Director | 1.0 M of 1.5 M |
||
| Rhythm Holding Company LLC | 021-200425 | Director | 11.0 M of 11.0 M |
||
| Vascular Pharmaceuticals Inc | 021-184519 | Director | 15.1 M of 25.1 M |
||
| Valeritas Inc | 021-166106 | Director | 75.2 M of 150.6 M |
||
| Valeritas Inc | 021-158315 | Director | 9.4 M of 10.0 M |
||
| Cerimon Pharmaceuticals Inc | 021-77816 | Director | 0.2 M of 0.2 M |
||
| Elixir Pharmaceuticals Inc | 021-44911 | Director | 12.0 M of 25.0 M |
||
| Xanodyne Pharmaceuticals Inc | 021-79890 | Director | 87.8 M of 87.8 M |
||
| MPM Asset Management LLC | |||||
| MPM BioVentures V LP | 021-138701 | Promoter | 69.1 M | 12.6 M | |